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in the patients with primary biliary cholangitis (PBC) and systemic lupus erythematosus (SLE) several years before the disease onset. [1] [2] [3] ANA can directly act on the mitosis of karyocyte and stagnate the mitotic cycle at different stages, leading to the disorder of DNA synthesis and protein production, and which may further block the metabolism of various tissues, and even cause morphological and structural changes and the loss of function. Therefore, the vital tissues and vigorous organs for body metabolism have become the targets of ANA attack, such as liver, hematological system, epithelial tissue, and so on, which are also the initial sites of clinical symptoms in ANA-positive patients. Unfortunately, these symptoms are rarely connected to abnormal ANA by doctors in basic hospitals, which usually lead to a high rate of misdiagnosis in population.
Therefore, we conducted an epidemiological investigation of ANA in healthy population and further explored the clinical characteristics in individuals with serum-positive AMA-M2 and anti-SSA antibodies, so that we could provide necessary data for clinical practice.
| MATERIAL S AND ME THODS

| Subjects
We collected samples from 25 110 residents who received health checkup in Baoding NO.1 central hospital, Baoding, Hebei, China, from January 2015 to June 2018. These participants included workers, peasants, cadres, students, kindergartens, and so on. The age range of the subjects was from 4 months to 93 years old.
The subjects were healthy individuals and patients diagnosed by AID, and those who may cause ANA positive in chronic active hepatitis, tuberculosis, and chronic infection have been excluded. In order to ensure the specificity of the results and exclude the effects of some interference factors, such as the elderly, some drugs, malignant diseases, and so on, we only chose the individuals with ANA titer >1:320. On the premise of the patient's voluntary, 15 specific antibody were also analyzed, including anti-SSA and anti-M2. The control group was negative for antibody detection, and the sex ratio was basically the same to that of the positive population. The study was approved by the Ethics Committee of Baoding NO.1 central hospitals, and informed consent was acquired from each individual.
| Detection of antibody
Blood samples (3 mL) were collected from 25 110 residents who received health checkup. Serum was separated by centrifugation at 900 g for 5 minutes. ANA were tested by indirect immunofluorescence on HEp-2 cells according to the manufacturer's instructions (Euroimmun AG). As a result, 1489 positive samples were further used by line immunoassay (LIA; Euroimmun AG) for 15 specific autoantibodies (anti-Ro52, anti-nRNP, anti-Sm, anti-SSA, anti-SSB, anti-Scl-70, anti-Jo-1, anti-CNEPB, anti-dsDNA, anti-PCNA, anti-His, anti-Nuc, anti-RIB, anti-M2, and anti-PMScl-70). The serum for LIA test was diluted 1:100.
EUROBlotMaster (Euroimmun AG) and EUROLineScan (Euroimmun AG) were used to complete the operation and for test result interpretation, respectively.
| Statistical analysis
Statistical analysis was performed using SPSS Version 19.0 software (IBM Corp.). P < 0.05 was considered as statistically significant.
Comparison of counting data between groups was performed using chi-square test.
| RE SULT
| Positive rate of ANA in healthy population
A total of 25 110 residents were detected for ANA, including 12 640 males and 12 470 females. The positive rate of ANA titer >1:100 was 14.01% (3519/25 110), of which 9.04% of males (1143/12 640) and 19.05% of females (2376/12 470) was positive. The positive rate of ANA titer >1:320 was 5.93% (1489/25 110), of which 3.21% of males (406/12 640) and 8.68% of female (1083/12 470) was positive ( Table 1 ). The difference in positive rates between genders was statistically significant.
| Distribution of ANA-specific antibodies in 1489 patients with ANA titer >1:320
A total of 1489 positive samples with ANA >1:320 population were further tested by line immunoassay (LIA) for 15 specific autoantibodies. The positive rate of 15 specific antibodies was 44.29% (659/ 1489). The top three antibodies were anti-Ro-52 (212), AMA-M2 (189), and anti-SSA (144) (Figure 1 ).
| Statistical analysis of PBC-related laboratory indicators in AMA-M2-positive patients
By detecting 15 specific antibodies, we found the high positive rate of AMA-M2 with a total of 189 of AMA-M2-positive cases, including 39 males and 150 females. Samples from 40 males and 160 females with negative ANA were randomly selected as controls. Our data demonstrated that the abnormal rate of blood routine, liver function, and other clinical indicators in 189 of AMA-M2-positive cases was significantly different from that in the control group (Table 2) . We detected the biochemical indexes of liver function and found that alkaline phosphatase (ALP) was elevated in 70 patients, and the diagnostic rate of PBC was 37.4% ( Table 3 ). 
| Analysis of laboratory test indicators for anti-SSA antibody-positive population
| D ISCUSS I ON
In this study, we retrospectively analyzed the positive rate of ANA in healthy population aged 4 months to 93 years old. The results showed that the positive rate of ANA titer >1:100 was 14.01%, which was basically consistent with Satoh's ANA test in healthy people over 12 years old in the United States. 4 The positive rate of females with ANA titer >1:100 was 2.08 times that of males, and positive rate of females with ANA titer >1:320 was 2.67 times that of males. It is suggested that female patients were at high risk of autoimmune diseases.
We detected specific antibodies in population with high titer of ANA positive and found that the top three positive antibodies were anti-Ro-52, AMA-M2, and anti-SSA antibodies, respectively. In this study, we focused on AMA-M2 and anti-SSA antibodies which had high specificity in autoimmune disease (AID). The fourth stage is decompensated stage, which is characterized by jaundice, ascites, and encephalopathy. Once the patients go through this phase and develop jaundice, the disease rapidly deteriorates.
Anti
The average time from this period to death or liver transplantation is 4 years. We only found jaundice in 4 patients in this survey. It is related to the fact that the subjects of our study were healthy population rather than patients. Therefore, mass screening for the AMA-M2 antibody in those who had abnormal symptoms of blood routine and liver function and abdominal discomfort, allergic, and fatigue is important for improving diagnosis rate, facilitating early diagnosis, promoting early treatments of PBC, and reducing the occurrence of malignant complications.
Anti-SSA antibody is an immunoglobulin produced by the immune system in response to a group of small ribonucleic acid proteins in autologous cells. Many studies have confirmed that this antibody is an invasive autoantibody. 11, 12 A study of patients with SLE found that anti-SSA antibodies can adhere to the surface of granulocytes in patients with SLE and activate the complement system to cause granulocyte destruction. 13 Other studies have shown that when the separated lymphocytes from patients with neurological lupus were cultured with serum containing autologous anti-SSA antibody, the apoptotic rate increased significantly. As we found in this study, the blood components of anti-SSA antibodypositive population decreased significantly compared with the control group, which is likely to be caused by the antibody itself.
Previous studies have shown that the prominent manifestation of humoral immune abnormalities in patients with pSS is hyperglobulinemia, especially the increase in IgG. Hyperglobulinemia promotes the increase in erythrocyte sedimentation rate (ESR). 14 Abbreviations: ESR, erythrocyte sedimentation rate; RF, rheumatoid factor. a Abnormal blood routine: single decrease and mixed decrease in erythrocyte, leukocyte, and platelet. b Abnormal liver function: single increase and mixed increase in alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltranspeptidase (GGT), alkaline phosphatase (ALP), total bilirubin (TBIL), conjugated bilirubin (CBIL).
TA B L E 4 Distribution of laboratory
test indicators in anti-SSA antibodypositive population and control group diseases, although it does not have high specificity, but as an antinuclear antibody with high positive rate, it is usually combined with anti-SSA antibody, which is of auxiliary diagnosis and differential diagnosis value. Yaping Guo https://orcid.org/0000-0002-2614-3048
| CON CLUS ION
